Flibanserin, sold under the brand name Addyi, is a non-hormonal medication approved by the FDA to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. It doesn’t work like Viagra, which increases blood flow. Instead, it targets specific brain chemicals.
How Flibanserin Works
Flibanserin affects serotonin, dopamine, and norepinephrine levels in the brain. Specifically, it’s a serotonin receptor antagonist and a partial agonist at other receptors. This complex interaction influences brain areas related to sexual desire, potentially increasing libido. Think of it as subtly adjusting the brain’s chemistry to improve sexual response.
Important Considerations
Dosage: Addyi is typically taken once daily at bedtime. This is crucial; it must be taken consistently for it to be most effective. Side effects: Common side effects include dizziness, nausea, sleepiness, and fatigue. These are generally mild and tend to lessen over time. Alcohol Interaction: Combining Addyi with alcohol is contraindicated; it can significantly increase the risk of low blood pressure and fainting. Medical History: You must discuss your complete medical history with your doctor before starting Addyi, especially regarding liver conditions and the use of other medications. Effectiveness: Studies show Addyi increases the number of satisfying sexual events per month for some women, but results vary.
Who Should Consider Flibanserin?
Flibanserin is an option for premenopausal women experiencing persistently low sexual desire that causes distress. However, it’s not a solution for all women with low libido, and your doctor will help you determine if it’s right for you. A thorough discussion of your individual situation and medical history is vital before starting any medication for HSDD.
